Skip to main content

Table 3 Risk of patient delay >90 days among women with primary BC in Estonia, 2008–2010

From: Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia

 

No of patients (row%)a

  
 

No delay (n = 567)

Delay >90 days (n = 119)

Crude OR (95% CI)

Multivariate ORb(95% CI)

Age at first symptom (years)

    

 <50

147 (87.0)

22 (13.0)

1.00

1.00

 50–64

160 (83.8)

31 (16.2)

1.29 (0.72–2.34)

1.94 (1.00–3.75)

 ≥65

260 (79.7)

66 (20.3)

1.70 (1.01–2.86)

2.27 (1.23–4.20)

Year of interview

    

 2008

100 (85.5)

17 (14.5)

1.00

1.00

 2009

233 (84.1)

44 (15.9)

1.11 (0.61–2.04)

1.10 (0.58–2.07)

 2010

234 (80.1)

58 (19.9)

1.46 (0.81–2.63)

1.48 (0.79–2.77)

Education

    

 University

145 (87.9)

20 (12.1)

1.00

1.00

 Secondary, vocational

322 (82.3)

69 (17.7)

1.55 (0.91–2.65)

1.45 (0.83–2.54)

 Primary, basic

100 (76.9)

30 (23.1)

2.17 (1.17–4.05)

1.57 (0.78–3.13)

Smoking status

    

 Non-smokers, ex-smokers

479 (83.9)

92 (16.1)

1.00

1.00

 Current smokers

88 (76.5)

27 (23.5)

1.60 (0.98–2.60)

2.09 (1.21–3.61)

Number of close persons to confide in

    

 More than two

304 (80.0)

76 (20.0)

1.00

1.00

 One or two

229 (84.5)

42 (15.5)

0.73 (0.48–1.11)

0.68 (0.44–1.04)

 None

34 (97.1)

1 (2.9)

0.12 (0.02–0.87)

0.09 (0.01–0.67)

Initial symptom

    

 Painless breast lump

437 (83.9)

84 (16.1)

1.00

1.00

 Breast pain

54 (84.4)

10 (15.6)

0.96 (0.47–1.97)

0.94 (0.45–1.98)

 Other symptoms

76 (75.2)

25 (24.8)

1.71 (1.03–2.85)

1.84 (1.08–3.16)

Previous benign breast problems

    

 No

426 (83.5)

84 (16.5)

1.00

1.00

 Yes

141 (80.1)

35 (19.9)

1.26 (0.81–1.95)

1.65 (1.01–2.67)

Prior mammograms

    

 Yes

267 (86.4)

42 (13.6)

1.00

1.00

 No

300 (79.6)

77 (20.4)

1.63 (1.08–2.46)

1.83 (1.13–2.95)

Information on BC during 12 months before initial symptoms

    

 From at least two sources

296 (86.3)

47 (13.7)

1.00

1.00

 From one source

161 (83.0)

33 (17.0)

1.29 (0.79–2.10)

1.22 (0.73–2.03)

 None

110 (73.8)

39 (26.2)

2.23 (1.38–3.60)

1.77 (1.05–2.99)

  1. apatients with missing data excluded.
  2. bodds ratio simultaneously adjusted for all variables in the table.